Only EBUS-Guided Mediastinal Lymph Node Cryobiopsy Enabled Immunotherapy in a Patient with Non-Small Cell Lung Cancer

Potential application of cryobiopsy for histo-molecular characterization of mediastinal lymph nodes in patients with thoracic malignancies: a case presentation series and implications for future developments

(2022) Carlo Genova et al.   BMC Pulmonary Medicine

Mediastinal “deep freeze”—transcarinal lymph node cryobiopsy

(2022) Evgeni Gershman et al.   Thoracic Cancer

Transbronchial mediastinal cryobiopsy in the diagnosis of mediastinal lesions: a randomised trial

(2021) Jing Zhang et al.   EUROPEAN RESPIRATORY JOURNAL

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%

(2021) Martin Reck et al.   JOURNAL OF CLINICAL ONCOLOGY

Adverse events of immunotherapy in non-small cell lung cancer: A systematic review and network meta-analysis

(2021) Chunyang Zhou et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Cryobiopsy increases the EGFR detection rate in non-small cell lung cancer

(2020) Maik Haentschel et al.   LUNG CANCER

First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status

(2020) Francesco Facchinetti et al.   EUROPEAN JOURNAL OF CANCER

Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sites

(2019) Katsuhiro Yoshimura et al.   LUNG CANCER

Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies

(2019) Kaname Nosaki et al.   LUNG CANCER

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

(2019) Suresh S. Ramalingam et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis

(2018) Rawad Elias et al.   Journal for ImmunoTherapy of Cancer

OUP accepted manuscript

(2018)   ANNALS OF ONCOLOGY

Adequacy of Ebus-Tbna Specimen For Mutation Analysis of Lung Cancer

(2018) Tugba Cicek et al.   Clinical Respiratory Journal

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

(2016) Martin Reck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)

(2015) C. Zhou et al.   ANNALS OF ONCOLOGY

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

(2015) James Chih-Hsin Yang et al.   LANCET ONCOLOGY